Cited by 297Estrogen and related hormone effectsProtein Kinase Regulation and GTPase SignalingReceptor Mechanisms and Signaling

Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase

Open access
Rogatsky, Inez, Logan, Susan K., Garabedian, Michael J.·1998·Proceedings of the National Academy of Sciences

Abstract

The mitogen-activated protein kinases ERK (extracellular signal-regulated kinase), JNK (c-Jun N-terminal kinase), and p38 phosphorylate and activate transcription factors that promote proliferative and inflammatory responses, whereas glucocorticoid receptor (GR) activation inhibits cell growth and inflammation. We demonstrate that JNK and ERK but not p38 phosphorylate GR in vitro primarily at Ser-246. Selective activation of either ERK or JNK in vivo inhibits GR-mediated transcriptional activation, which depends on receptor phosphorylation at Ser-246 by JNK but not ERK. Thus, JNK inhibits GR transcriptional activation by direct receptor phosphorylation, whereas ERK does so indirectly. We propose that phosphorylation of GR by JNK or of a GR cofactor by ERK provides mechanisms to ensure the rapid inhibition of GR-dependent gene expression when it conflicts with mitogenic or proinflammatory signals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.95.5.2050

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibition of GR function by activation of ERK is believed to be in part related to phosphorylation of GR cofactors.

    “Inhibition of GR function by activation of ERK is believed to be in part related to phosphorylation of GR cofactors.65”

    From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [65]

  • MAPK (ERK and JNK) can decrease GR nuclear transport and affinity to cofactors via phosphorylation.

    “Reciprocally, MAPK (ERK and JNK) can decrease GR nuclear transport and affinity to cofactors via phosphorylation (Rogatsky et al., 1998).”

    From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as Rogatsky et al., 1998

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [11]Davis R J. J Biol Chem. 1993;268:14553–14556. [PubMed] [Google Scholar]
  2. [15]Westwick J K, Weitzel C, Minden A, Karin M, Brenner D A. J Biol Chem. 1994;269:26396–26401. [PubMed] [Google Scholar]
  3. [24]Krstic M D. Ph.D. thesis. San Francisco: Univ. of California; 1995. [Google Scholar]
  4. [32]Xu X, Barry D C, Settleman J, Schwartz M A, Bokoch G M. J Biol Chem. 1994;269:23569–23574. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Rogatsky, I., Logan, S. K., & Garabedian, M. J.
Affiliations
NYU Langone Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
1998-03-03
Volume
95
Issue
5
Pages
2050-2055
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1976548850
Cited by
297
References
35
Citations by year
2026: 4 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 1 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 6 · 2015: 11 · 2014: 8 · 2013: 13 · 2012: 13
FWCI
7.07
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
glucocorticoid receptor, c-Jun N-terminal kinase, ERK, p38 MAPK, receptor phosphorylation, transcriptional activation, mitogen-activated protein kinase, inflammation, cell proliferation, gene expression regulation
MeSH terms
Animals, Dexamethasone, HeLa Cells, Humans, Peptide Mapping, Phosphopeptides, Phosphorylation, Receptors, Glucocorticoid, Recombinant Fusion Proteins, Osteosarcoma, Serine, Transcription Factors, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Calcium-Calmodulin-Dependent Protein Kinases, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review